Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18831907 | 0.89 | — | — | |
| SCHEMBL15962875 | 0.85 | — | — | |
| SCHEMBL18842922 | 0.81 | — | — | |
| SCHEMBL23921828 | 0.81 | — | — | |
| SCHEMBL19646654 | 0.81 | — | — | |
| SCHEMBL20427540 | 0.81 | — | — | |
| SCHEMBL18055565 | 0.80 | — | — | |
| SCHEMBL19852635 | 0.80 | — | — | |
| SCHEMBL13464222 | 0.79 | — | — | |
| SCHEMBL24095318 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220211866-A1 | MOMP TELONANOPARTICLES, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2022-07-07 | — | — | US | disclosed |
| US-11207422-B2 | MOMP telonanoparticles, and related compositions, methods and systems | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2021-12-28 | — | — | US | disclosed |
| US-20200046848-A1 | MOMP TELONANOPARTICLES, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | U.S. DEPARTMENT OF ENERGY | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200046848-A1 | MOMP TELONANOPARTICLES, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | CETP, PCTP, MTTP | ALDH1A1 4872/4885 |
| US-11207422-B2 | MOMP telonanoparticles, and related compositions, methods and systems | CETP, PCTP, MTTP | ALDH1A1 4872/4885 |
| US-20220211866-A1 | MOMP TELONANOPARTICLES, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | CETP, PCTP, MTTP | ALDH1A1 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.